| 1 | CEBPA, FCAR, GABPA
|
| Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells.
|
| Shimokawa T, Nunomura S, Fujisawa D, Ra C.
|
| Biochim Biophys Acta 1829(11):1207-17. doi: 10.1016/j.bbagrm.2013.09.004. Epub 2013 Sep 27. 2013
|
| 2 | FCAR
|
| Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy.
|
| Bakema JE, Ganzevles SH, Fluitsma DM, Schilham MW, Beelen RH, Valerius T, Lohse S, Glennie MJ, Medema JP, van Egmond M.
|
| J Immunol 187(2):726-32. doi: 10.4049/jimmunol.1002581. Epub 2011 Jun 8.
2011
|
| 3 | CRP, FCAR
|
| Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein.
|
| Lu J, Marjon KD, Marnell LL, Wang R, Mold C, Du Clos TW, Sun P.
|
| Proc Natl Acad Sci U S A 108(12):4974-9. doi: 10.1073/pnas.1018369108. Epub 2011 Mar 7.
2011
|
| 4 | CEBPA, FCAR, GABPA
|
| Amino acid residues in the beta3 strand and subsequent loop of the conserved ETS domain that mediate basic leucine zipper (bZIP) recruitment and potentially distinguish functional attributes of Ets proteins.
|
| Shimokawa T, Nunomura S, Enomoto Y, Ra C.
|
| Biochem J 430(1):129-39. doi: 10.1042/BJ20091742.
2010
|
| 5 | FCAR
|
| Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.
|
| Vuong MT, Hahn-Zoric M, Lundberg S, Gunnarsson I, van Kooten C, Wramner L, Seddighzadeh M, Fernström A, Hanson LÅ, Do LT, Jacobson SH, Padyukov L.
|
| Kidney Int 78(12):1281-7. doi: 10.1038/ki.2010.314. Epub 2010 Sep 1.
2010
|
| 6 | FCAR
|
| Endocytosis of FcalphaR is clathrin and dynamin dependent, but its cytoplasmic domain is not required.
|
| Peng M, Yin N, Zhang W.
|
| Cell Res 20(2):223-37. doi: 10.1038/cr.2009.120. Epub 2009 Oct 27.
2010
|
| 7 | FCAR, PPP2CA
|
| Inside-out regulation of Fc alpha RI (CD89) depends on PP2A.
|
| Bakema JE, Bakker A, de Haij S, Honing H, Bracke M, Koenderman L, Vidarsson G, van de Winkel JG, Leusen JH.
|
| J Immunol 181(6):4080-8.
2008
|
| 8 | FCAR
|
| IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth.
|
| Kanamaru Y, Tamouza H, Pfirsch S, El-Mehdi D, Guérin-Marchand C, Pretolani M, Blank U, Monteiro RC.
|
| Blood 109(1):203-11. Epub 2006 Sep 21.
2007
|
| 9 | FCAR
|
| A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA.
|
| Wines BD, Willoughby N, Fraser JD, Hogarth PM.
|
| J Biol Chem 281(3):1389-93. Epub 2005 Nov 17. 2006
|
| 10 | FCAR
|
| C/EBPalpha functionally and physically interacts with GABP to activate the human myeloid IgA Fc receptor (Fc alphaR, CD89) gene promoter.
|
| Shimokawa T, Ra C.
|
| Blood 106(7):2534-42. Epub 2005 May 31.
2005
|
| 11 | FCAR
|
| Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells.
|
| Pasquier B, Lepelletier Y, Baude C, Hermine O, Monteiro RC.
|
| J Leukoc Biol 76(6):1134-41. Epub 2004 Sep 15. 2004
|
| 12 | FCAR
|
| Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue.
|
| Hamre R, Farstad IN, Brandtzaeg P, Morton HC.
|
| Scand J Immunol 57(6):506-16. 2003
|
| 13 | FCAR
|
| Identification and characterization of the promoter for the gene encoding the human myeloid IgA Fc receptor (FcalphaR, CD89).
|
| Shimokawa T, Tsuge T, Okumura K, Ra C.
|
| Immunogenetics 51(11):945-54. 2000
|
| 14 | FCAR
|
| Structure of the gene for the human myeloid IgA Fc receptor (CD89).
|
| De Wit TPM, et al.
|
| J Immunol 155 : 1203-1209. 1995
|
| 15 | FCAR
|
| The gene for the human IgA Fc receptor maps to 19q13.4.
|
| Kremer EJ, et al.
|
| Hum Genet 89 : 107-108. 1992
|
| 16 | IGFCR@, FCAR
|
| The polymorphic Fc gamma receptor II gene maps to human chromosome 1q.
|
| Grundy HO.
|
| Immunogenetics 29 : 331. 1989
|